MIPT researchers have collaborated with Atlas Biomedical Holding and developed a new bioinformatics data analysis method. The developed program, EphaGen, can be used for quality control when diagnosing genetic diseases. The team published the article in Nucleic Acid Research.
The mapping of the human genome in the early 21st century and understanding the nucleic acid sequence have provided ample opportunities for research on both genetic diseases and genetic predisposition.
This has become possible after the development of next-generation sequencing, or NGS -- new methods for determining a DNA sequence. They produce faster results in a less costly procedure and can be integrated into routine clinical practice.
While the diseases that can be caused by defects in several distinct DNA segments -- called polygenic disorders -- are still the province of researchers, DNA diagnostics of single-gene disorders associated with a defect in a specific DNA segment (known as Mendelian disorders) is now a standard of care in medical genetics.
The main challenge when using NGS data in clinical practice is the need for an unambiguous answer to whether a patient has a mutation.
When a mutation is not detected, confidence that such findings are not associated with low data quality is required. Special quality metrics have been introduced to ensure this; however, they only provide indirect evidence of the presence or absence of a mutation.
Researchers from MIPT and Atlas have developed EphaGen software, which uses a new evaluation method to provide a straight answer to that question.
Given a spectrum of the clinically relevant variants of interest, it associates these NGS data with a single parameter. Based on the inner algorithm, this parameter resembles diagnostic sensitivity and may thus be used to decide whether the collected data are suitable for clinical interpretation or not.
"Interpretation of laboratory data has become more complex due to the rapid introduction of new sequencing methods in clinical practice," said the article's lead author, Maxim Ivanov, a PhD student at the MIPT Department of Bioinformatics.
"A doctor often wants a straight answer as to whether a mutation was detected or not. However, a laboratory is often unable to provide such an answer due to numerous 'buts.' Such as, 'We have not detected a mutation, BUT we haven't analyzed one gene, or the analysis of some genes was incomplete, or there was a technical failure in the analysis of certain regions of some genes.'
NGS is a large-scale technology, so a specific important DNA segment may remain unanalyzed, without this being noticed."
"We have implemented an integral characteristic that will enable a doctor to assess the reliability of the 'no mutation' result, and will provide a unified language for communication between a clinician and the laboratory. And of course, there can be numerous other applications, too. As we demonstrated in our study, it may assist labs to perform head-to-head comparison between different technical solutions or detect the source of failure, and so on," Ivanov added.
The developed EphaGen software provides a novel approach for performing measurement in routine clinical NGS testing and can be easily implemented into existing clinical workflows as a measure of quality control.
The research was conducted with the support of the Russian Foundation for Basic Research.
Varvara Bogomolova | EurekAlert!
Structual color barcode micromotors for multiplex biosensing
21.01.2020 | Science China Press
Cyanobacteria in water and on land identified as source of methane
21.01.2020 | Forschungsverbund Berlin
For years, a new synthesis method has been developed at TU Wien (Vienna) to unlock the secrets of "strange metals". Now a breakthrough has been achieved. The results have been published in "Science".
Superconductors allow electrical current to flow without any resistance - but only below a certain critical temperature. Many materials have to be cooled down...
KIT researchers develop novel composites of DNA, silica particles, and carbon nanotubes -- Properties can be tailored to various applications
Using DNA, smallest silica particles, and carbon nanotubes, researchers of Karlsruhe Institute of Technology (KIT) developed novel programmable materials....
Styrofoam or copper - both materials have very different properties with regard to their ability to conduct heat. Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz and the University of Bayreuth have now jointly developed and characterized a novel, extremely thin and transparent material that has different thermal conduction properties depending on the direction. While it can conduct heat extremely well in one direction, it shows good thermal insulation in the other direction.
Thermal insulation and thermal conduction play a crucial role in our everyday lives - from computer processors, where it is important to dissipate heat as...
In order to advance the transfer of research developments from the field of quantum sensor technology into industrial applications, an application laboratory is being established at Fraunhofer IAF. This will enable interested companies and especially regional SMEs and start-ups to evaluate the innovation potential of quantum sensors for their specific requirements. Both the state of Baden-Württemberg and the Fraunhofer-Gesellschaft are supporting the four-year project with one million euros each.
The application laboratory is being set up as part of the Fraunhofer lighthouse project »QMag«, short for quantum magnetometry. In this project, researchers...
Microtubules, filamentous structures within the cell, are required for many important processes, including cell division and intracellular transport. A...
16.01.2020 | Event News
15.01.2020 | Event News
07.01.2020 | Event News
21.01.2020 | Materials Sciences
21.01.2020 | Health and Medicine
21.01.2020 | Life Sciences